Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q420262> ?p ?o }
Showing triples 1 to 90 of
90
with 100 triples per page.
- Q420262 subject Q7204516.
- Q420262 subject Q7486806.
- Q420262 subject Q8256055.
- Q420262 subject Q8707608.
- Q420262 subject Q8852392.
- Q420262 subject Q8919936.
- Q420262 abstract "Rivaroxaban (BAY 59-7939) is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose. The effects last approximately 8–12 hours, but factor Xa activity does not return to normal within 24 hours so once-daily dosing is possible.".
- Q420262 atcPrefix "B01".
- Q420262 atcSuffix "AX06".
- Q420262 bioavailability "80.0".
- Q420262 casNumber "366789-02-8".
- Q420262 drugbank "DB06228".
- Q420262 fdaUniiCode "9NDF7JZ4M3".
- Q420262 iupacName "(S)-5-chloro-N-{[2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl} thiophene-2-carboxamide".
- Q420262 pubchem "6433119".
- Q420262 thumbnail Rivaroxaban2DCSD.svg?width=300.
- Q420262 wikiPageExternalLink index.php.
- Q420262 wikiPageExternalLink ?ligand=RIV.
- Q420262 wikiPageExternalLink xarelto-prescribing-info.html.
- Q420262 wikiPageWikiLink Q101026.
- Q420262 wikiPageWikiLink Q1057591.
- Q420262 wikiPageWikiLink Q1251001.
- Q420262 wikiPageWikiLink Q12796879.
- Q420262 wikiPageWikiLink Q1340807.
- Q420262 wikiPageWikiLink Q14821011.
- Q420262 wikiPageWikiLink Q14861061.
- Q420262 wikiPageWikiLink Q14864419.
- Q420262 wikiPageWikiLink Q14865111.
- Q420262 wikiPageWikiLink Q152051.
- Q420262 wikiPageWikiLink Q166019.
- Q420262 wikiPageWikiLink Q1693864.
- Q420262 wikiPageWikiLink Q1762339.
- Q420262 wikiPageWikiLink Q17911915.
- Q420262 wikiPageWikiLink Q179217.
- Q420262 wikiPageWikiLink Q182338.
- Q420262 wikiPageWikiLink Q190016.
- Q420262 wikiPageWikiLink Q2044524.
- Q420262 wikiPageWikiLink Q204711.
- Q420262 wikiPageWikiLink Q21011234.
- Q420262 wikiPageWikiLink Q215118.
- Q420262 wikiPageWikiLink Q220570.
- Q420262 wikiPageWikiLink Q2361887.
- Q420262 wikiPageWikiLink Q267896.
- Q420262 wikiPageWikiLink Q2750727.
- Q420262 wikiPageWikiLink Q2751330.
- Q420262 wikiPageWikiLink Q2852541.
- Q420262 wikiPageWikiLink Q304088.
- Q420262 wikiPageWikiLink Q323936.
- Q420262 wikiPageWikiLink Q407431.
- Q420262 wikiPageWikiLink Q411377.
- Q420262 wikiPageWikiLink Q414462.
- Q420262 wikiPageWikiLink Q421218.
- Q420262 wikiPageWikiLink Q423640.
- Q420262 wikiPageWikiLink Q425555.
- Q420262 wikiPageWikiLink Q461809.
- Q420262 wikiPageWikiLink Q4898219.
- Q420262 wikiPageWikiLink Q500256.
- Q420262 wikiPageWikiLink Q5222570.
- Q420262 wikiPageWikiLink Q621636.
- Q420262 wikiPageWikiLink Q6431240.
- Q420262 wikiPageWikiLink Q7120529.
- Q420262 wikiPageWikiLink Q7204516.
- Q420262 wikiPageWikiLink Q7486806.
- Q420262 wikiPageWikiLink Q766195.
- Q420262 wikiPageWikiLink Q815819.
- Q420262 wikiPageWikiLink Q8256055.
- Q420262 wikiPageWikiLink Q857288.
- Q420262 wikiPageWikiLink Q8707608.
- Q420262 wikiPageWikiLink Q8852392.
- Q420262 wikiPageWikiLink Q8880.
- Q420262 wikiPageWikiLink Q8919936.
- Q420262 wikiPageWikiLink Q903523.
- Q420262 wikiPageWikiLink Q906280.
- Q420262 wikiPageWikiLink Q9368.
- Q420262 atcPrefix "B01".
- Q420262 atcSuffix "AX06".
- Q420262 bioavailability "14400.0".
- Q420262 casNumber "366789".
- Q420262 drugbank "DB06228".
- Q420262 iupacName "-5".
- Q420262 pubchem "6433119".
- Q420262 unii "9".
- Q420262 type ChemicalSubstance.
- Q420262 type Drug.
- Q420262 type ChemicalObject.
- Q420262 type Thing.
- Q420262 type Q8386.
- Q420262 comment "Rivaroxaban (BAY 59-7939) is an oral anticoagulant invented and manufactured by Bayer; in a number of countries it is marketed as Xarelto. In the United States, it is marketed by Janssen Pharmaceutica. It is the first available orally active direct factor Xa inhibitor. Rivaroxaban is well absorbed from the gut and maximum inhibition of factor Xa occurs four hours after a dose.".
- Q420262 label "Rivaroxaban".
- Q420262 depiction Rivaroxaban2DCSD.svg.